PEREGRINE PHARMACEUTICALS Stock Price
$1.7 
Change:
0.00 0.00% Volume:
266,482
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 1.73 | Todays Low: 1.64 | Open: 1.7 | Last Close: 1.62
52 Wk High: 5.5 | 52 Wk Low: 0.4223 | Todays Pivot: 1.69 | Pre market open: 1.7
Sector: 
Online News For Peregrine Pharmaceuticals
|
Encouraging News for Peregrine Pharma - Analyst Blog - NASDAQ
Fri, 24 May 2013 16:37Peregrine Pharmaceuticals ( PPHM ) recently received encouraging news when the company announced that the US Food and Drug Administration (FDA) has agreed on the design for the phase III registration trial for its oncology candidate, bavituximab.
|
|
National Bank of Greece (NYSE:NBG) executes recapitalisation plan, Peregrine ... - GSPInsider
Thu, 23 May 2013 08:25Peregrine Pharmaceuticals (NASDAQ:PPHM): In Wednesday's trading session, Peregrine Pharmaceuticals (NASDAQ:PPHM) dipped 4.82% and closed at $1.58. It opened at $1.70 per share, touched an intraday high of $1.75, before dropping down to close ...
|
|
Peregrine Pharmaceuticals Reaches Agreement With FDA on a Phase III Trial ... - Marketwire (press release)
Mon, 20 May 2013 12:49TUSTIN, CA--(Marketwired - May 20, 2013) - Peregrine Pharmaceuticals ( NASDAQ : PPHM), a biopharmaceutical company developing first-in-class monoclonal antibodies focused on the treatment and diagnosis of cancer, today announced that it has ...
|
|
Peregrine Pharma agrees with FDA on lung cancer trial design - Yahoo! News
Mon, 20 May 2013 13:49(Reuters) - Peregrine Pharmaceuticals said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental lung cancer drug. The late-stage trial will compare a combination of chemotherapy and ...
|
|
Peregrine Pharmaceuticals' Cancer Drug Moves to Late-Stage Trial - Wall Street Journal
Mon, 20 May 2013 15:04Peregrine Pharmaceuticals Inc. (PPHM) said it reached an agreement with the U.S. Food and Drug Administration on the design of a late-stage trial for its experimental cancer drug, increasing hopes the drug could eventually be approved despite ...
|
|
Stocks to Watch (UniPixel Inc, Real Goods Solar, Peregrine Pharmaceuticals ... - SBWire (press release)
Wed, 22 May 2013 13:17Peregrine Pharmaceuticals (NASDAQ:PPHM) shares declined 9.29% to $1.66. The company, on May 20, announced that it has reached agreement with the U.S. Food and Drug Administration (FDA) on a Phase III registration trial design of the company's lead ...
|
PPHM Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Peregrine Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for PPHM to choose from. Visit here to build your stock quote widget »
